Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Total Synthesis of 8-Hydroxy-dihydroergotamine, the Major Human Metabolite of Dihydroergotamine

Lookup NU author(s): Dr Manuel Monerris Mascaro, Dr Alistair Henderson, Dr Marta Drozdowska, Dr Michael HallORCiD, Alexandra Longcake, Lina Mardiana, Emeritus Professor Bernard Golding

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2026 by the authors. 8-Hydroxy-dihydroergotamine is the major human metabolite of the anti-migraine drug dihydroergotamine and is required, along with a stable isotope-labelled derivative, to aid metabolic studies. An efficient, scalable synthesis of the unlabelled compound is described via the coupling of dihydrolysergic acid to the tricyclic amino compound (2R,5S,8R,10aS,10bS)-2-amino-5-benzyl-10b-hydroxy-8-methoxy-2-methyltetrahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine-3,6(2H,5H)-dione. The tricycle was obtained by a convergent synthesis combining precursors from suitably protected L-glutamic acid and L-phenylalanine, and 2-bromo-2-methylmalonic acid. For the labelled molecule, the tricyclic precursor contained a pentadeutero benzyl group derived from [2,3,4,5,6-2H5]L-phenylalanine. Considerable experimentation was required to achieve optimal activation of dihydrolysergic acid for efficient amide formation with the tricycle’s amino function affording 8-methoxy-dihydroergotamine. The stereochemical integrity of an intermediate in this synthesis, ethyl (2R,5S,8R,10aS)-5-benzyl-10b-hydroxy-8-methoxy-2-methyl-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine-2-carboxylate, was validated by crystal structure analysis. Acid-catalysed hydrolysis of 8-methoxy-dihydroergotamine gave 8-hydroxy-dihydroergotamine. Pentadeuterated 8-hydroxy-dihydroergotamine was obtained in an analogous manner from [2,3,4,5,6-2H5]L-phenylalanine. Both 8-hydroxy-dihydroergotamine and its 2H5-derivative were obtained as an equilibrating mixture of C-8 epimers (diastereomers), with the major isomer having (R)-configuration according to 1H NMR analysis. The syntheses described enable the routine synthesis of 50–100 mg quantities of each target molecule.


Publication metadata

Author(s): Monerris Mascaro M, Henderson AP, Drozdowska M, Richardson R, Nagel-Savage D, Hall MJ, Longcake A, Mardiana L, Golding BT

Publication type: Article

Publication status: Published

Journal: Molecules

Year: 2026

Volume: 31

Issue: 9

Online publication date: 06/05/2026

Acceptance date: 23/04/2026

Date deposited: 26/05/2026

ISSN (electronic): 1420-3049

Publisher: MDPI

URL: https://doi.org/10.3390/molecules31091547

DOI: 10.3390/molecules31091547

Data Access Statement: The original contributions presented in this study are included in the article and Supplementary Materials. Further inquiries can be directed to the corresponding author.

PubMed id: 42123908


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Engineering and Physical Sciences Research Council, UK (EP/W021129/1)
Universitas Indonesia

Share